Treatment and diagnosis of macrophage mediated disease
Details for Australian Patent Application No. 2007229371 (hide)
International Classifications
Event Publications
1 November 2007 Complete Application Filed
8 November 2007 Application Open to Public Inspection
Published as AU-B-2007229371
14 July 2011 Application Accepted
Published as AU-B-2007229371
28 July 2011 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 04 Jul 2011. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
27 October 2011 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 06 Oct 2011. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
17 November 2011 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 04 Jul 2011
16 February 2012 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 06 Oct 2011
23 February 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007229372-An access control mechanism for web applications
2007229370-5-substituted 1,1-dioxo-1,2,5-thiazolidine-3-one derivatives as PTPase 1B inhibitors
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser